biogen ceo michel vounatsos to step down following troubled alzheimer's drug launch
Published 2 years ago • 1.3K plays • Length 1:18Download video MP4
Download video MP3
Similar videos
-
7:54
biogen ceo michel vounatsos on seeking fda approval for new alzheimer's drug
-
5:41
biogen ceo michel vounatsos: we need to be the 'tesla' of drug pricing model | cnbc
-
3:55
biogen ceo's surprising step-down
-
3:49
biogen ceo on fda approval for its alzheimer's drug
-
5:17
biogen ceo: alzheimer's drug shows positive results
-
4:41
elon musk spotted at us congress for benjamin netanyahu’s address
-
1:01:48
why pharmaceuticals are so complicated in the u.s. | cnbc marathon
-
3:01
potential breakthrough: new treatment for alzheimer's
-
1:48
biogen reopens following fda approval of company's alzheimer drug
-
3:00
biogen shares drop as big clinics say they won't administer controversial alzheimer's drug
-
16:02
what’s the controversy behind biogen’s alzheimer’s drug?
-
2:56
biogen shares spike after fda approves alzheimer's drug
-
6:51
biogen has breakthrough alzheimer's drug
-
2:44
we have to mitigate inflation by becoming more efficient: akzonobel
-
4:39
jd vance’s biggest billionaire donors
-
3:14
investors should have known better to blame biogen for alzheimer's drug failure: wsj reporter
-
4:26
demand for biogen's new alzheimer's drug will surprise to the upside, says piper sandler analyst
-
2:23
biogen to seek fda approval for alzheimer's drug aducanumab
-
2:54
biogen and eisai to reveal results of alzheimer's drug trial
-
5:04
what biogen halted its alzheimer's drug trial means for biotech investors
-
3:40
here's what the fda's endorsement of the alzheimer's drug leqembi means for biogen
-
6:21
big win for biogen: alzheimer's drug results spark huge gains